Atlas Trials

Refractory Splenic Marginal Zone Lymphoma

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Splenic Marginal Zone Lymphoma

RecordFirmDate
Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (NCT04836832)Narendranath Epperla2022-07-01
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas (NCT02332980)Mayo Clinic2015-02-19

Track Refractory Splenic Marginal Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.